LifeStance Health Group, Inc.
LFST
$6.45
-$0.08-1.23%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 264.06% | 118.08% | 83.71% | 103.36% | 84.18% |
| Total Depreciation and Amortization | -8.43% | -10.31% | -24.70% | -39.04% | -33.96% |
| Total Amortization of Deferred Charges | -36.07% | -39.05% | -39.29% | -40.80% | -21.02% |
| Total Other Non-Cash Items | -1.99% | 15.36% | -7.74% | 3.42% | 176.38% |
| Change in Net Operating Assets | -92.12% | -37.49% | 60.58% | 9.54% | -15.96% |
| Cash from Operations | -7.63% | 20.09% | 46.16% | 85.84% | 271.04% |
| Capital Expenditure | -73.16% | -103.74% | -51.76% | -40.44% | 44.80% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -73.16% | -103.74% | -51.76% | -40.44% | 44.80% |
| Total Debt Issued | -- | -- | -- | -- | 778.73% |
| Total Debt Repaid | 99.37% | -148.02% | -147.54% | -148.02% | -44,168.10% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -260.82% |
| Cash from Financing | 52.94% | 0.15% | -43.02% | -310.32% | -113.16% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -13.89% | -4.30% | 45.51% | 31.11% | 43.45% |